Arcturus Therapeutics Employee Directory
Biotechnology ResearchCalifornia, United States51-200 Employees
Arcturus Therapeutics is a mid-sized biotechnology company based in San Diego that develops messenger RNA medicines for liver and respiratory rare diseases. It combines drug-substance and product-manufacturing capabilities with its RNA-based therapeutics pipeline and related enabling platforms. Its portfolio includes candidates for conditions such as cystic fibrosis and ornithine transcarbamylase deficiency, as well as partnered vaccine programs for COVID-19 and influenza, developed through collaborations. The company maintains a global footprint through partnerships, including CSL Seqirus and U.S. BARDA for pandemic flu, and a Japan-based manufacturing joint venture, ARCALIS. Since its founding in 2013, Arcturus has expanded into vaccine programs and RNA therapeutics, with a 2025 launch of KOSTAIVE, a COVID-19 vaccine candidate.